the Apply of Continuity Blood Purication in Systemic Inflammatory Response Syndrome

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONC-11001830

Enrollment

Unknown

Registered

2011-12-27

Start date

2006-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Inflammatory Response Syndrome

Interventions

three:continuity blood purication

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. age>18; 2. including following cause of diseases: 1) severe trauma or burn; 2) severe infection; 3) various shock, esp infectivity and hemorrhagic shock; 4) overmuch blood transfusion(more than 3L/d); 5) acute drug or poisons intoxication,et al. 3. be fulfilled criteria for systemic inflammatory response syndrome: including the following two or more than two conditions: 1) temperature between 36 to 38 degree C; 2) heart rate is above 90 per minute; 3) breath is above 20 per minute or arterial partial pressure of carbon dioxide is below 32mmHg; 4) peripheral blood leucocyte is more than 12*10^9/L or lower than 4.0*10^9/L, or the ratio of premature leucocyte is more than 10%.

Exclusion criteria

Exclusion criteria: 1. the patients with 3 or more than 3 multiple organ dysfunction; 2. pregnant women.

Design outcomes

Primary

Measure	Time frame
achievement ratio of the treatment;	—

Secondary

Measure	Time frame
Acute physiological and chronic health estimation;sequential organ failure assessment score;plasma interleukin-6 (IL-6);oxygenation index;serum creatinin;	—

Contacts

Public ContactTang Feng

tangf1987@yahoo.cn+86 13308080290

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026